Uncategorized
This Medford Clinic Is Developing a Coronavirus Vaccine, and You Wouldn’t Even Know It
Since July, the institute has been one of the staging grounds for a quest to find a vaccine for the novel coronavirus, which causes a disease that has killed more than 700 people in Oregon, more than 230,000 in the US, and 1.2 million worldwide. And inside, Gregg Lucksinger, the interim medical director of the institute, taps a business card against an oval wooden table in a brightly lit corner room. He leans back in an office chair and reminisces about the lessons learned in Liberia, where he worked in an Ebola treatment unit in 2015. He hopes those lessons will aide him and his colleagues now.
“In [Liberia], the epidemic overwhelmed health systems…. It was really fascinating to see that,” he says. “And that’s what we’re struggling with in the United States to prevent from happening. We’ve been really on the edge in a few places.”
Lucksinger’s work in clinical research began in Austin, Texas, during the HIV epidemic of the 1980s. He went on to help develop vaccines and/or therapeutics for HIV, hepatitis C, and Ebola.
Now, another complicated and highly contagious virus threatens humanity. Lucksinger and the institute in Oregon are working on two Phase 3 COVID-19 vaccine trials. The first, produced by biotech startup Moderna (which has been proven to reduce the risk of COVID-19 infection by 94.5 percent), has wrapped up its enrollment period and moved to data collection, a process by which research coordinators follow up with volunteers to see if they’ve developed symptoms of or contract the coronavirus as they go about their daily lives. This stage could take a year or two. The second trial is for a vaccine produced by Novavax. Under the White House’s Operation Warp Speed (OWS), a $10 billion initiative, COVID-19 vaccine and therapeutic trials have been accelerated, compressing what typically takes years into months. By running various processes in parallel and increasing the number of volunteers from a couple hundred to at least 30,000 for each trial, OWS hopes to have a vaccine by early 2021.
-
Crime & Safety1 week ago
Father claims his child became unresponsive after falling from a tabIe after using a chair to gain access, and had already fallen off on several occasions in the past, after he beat the child to death
-
Crime & Safety2 days ago
Man claims he was preparing to take his own life only for his girIfriend to try to intervene by attempting to get the weapon from him with his finger on the trigger, during which the gun discharged, striking her in the head and killing her
-
Crime & Safety2 days ago
Woman broke down locked bedroom door only to intentionally shoot 6-month-old baby in the eye because ‘that was not her grandchiId,’ then believed she shouldn’t be punished for her actions; sentenced
-
Crime & Safety1 week ago
Husband, who claims ‘something just came over him’, walked around his family home before deciding to kill his partner, then intentionally shot his baby, killing him, because the child cried too much and it made him anxious; sentenced
-
Eugene1 week ago
Community members are invited to view the final design for Golden Gardens Park and share their feedback during a public meeting on Wednesday, November 13
-
Eugene1 week ago
The Eugene Police Department is inviting community members to join its Citizen’s Police Academy, offering a unique opportunity to learn about the inner workings of law enforcement
-
Eugene1 day ago
Eugene Police announced they successfully identified the woman previously known as “Jane Doe” following an outpouring of support from concerned community members
-
Eugene1 week ago
Eugene Springfield Fire responded to gas leak that prompted evacuations in downtown Eugene, no injuries reported